Use of pharmaceutical nanotechnology for the treatment of leishmaniasis
Rev. Soc. Bras. Med. Trop
;
52: e20180246, 2019. tab, graf
Article
in Portuguese
| LILACS
| ID: biblio-1041535
ABSTRACT
Abstract INTRODUCTION:
Leishmaniasis is a global public health concern. Currently available treatments are associated with considerable side effects. The use of nanotechnology has shown promise for improving efficacy and bioavailability and minimizing side effects.METHODS:
This study investigated available literature, including patents and scientific articles, to identify advances in the use of nanotechnology for the treatment of leishmaniasis.RESULTS:
Our findings revealed a stable number of patents and scientific articles published over the past five years.CONCLUSIONS:
There is a need to intensify research on the use of nanotechnology for the treatment of leishmaniasis.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Leishmaniasis
/
Nanotechnology
/
Biomedical Research
/
Antiprotozoal Agents
Type of study:
Prognostic study
Limits:
Humans
Language:
Portuguese
Journal:
Rev. Soc. Bras. Med. Trop
Journal subject:
Tropical Medicine
Year:
2019
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Universidade Federal do Piauí/BR
/
Universidade Federal do Rio de Janeiro/BR
/
Universidade Tiradentes/BR
/
Universidade de Sorocaba/BR
Similar
MEDLINE
...
LILACS
LIS